Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Real-world perioperative FLOT delivery in gastric and gastro-oesophageal junction adenocarcinoma: a single-centre service evaluation in a District General Hospital in the UK

Riya Sabharwal, View ORCID ProfileDivyalakshmi Bhaskaran
doi: https://doi.org/10.64898/2026.10.19.26365836
Riya Sabharwal
1KING’S COLLEGE HOSPITAL NHS FOUNDATION TRUST
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Divyalakshmi Bhaskaran
2St James’s University Hospitals, Leeds Teaching Hospitals, NHS Trust, Beckett Street, LS9 7TF
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Divyalakshmi Bhaskaran
  • For correspondence: divya.bhaskaran{at}nhs.net
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Although perioperative fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) is the standard neoadjuvant regimen for resectable gastric and gastro-oesophageal junction adenocarcinoma, evidence describing treatment delivery in routine clinical practice remains limited, particularly regarding relative dose intensity (RDI) and treatment completion.

Objectives To evaluate real-world delivery of preoperative FLOT chemotherapy, including treatment completion, progression to surgery, RDI, toxicity and exploratory changes in estimated lean body mass (LBM).

Methods A retrospective single-centre service evaluation included consecutive patients receiving neoadjuvant FLOT during 2024. Outcomes included treatment completion, surgery, RDI, toxicity, pathological response and estimated LBM. Descriptive statistics were used.

Results Twelve patients were included (median age 68.6 years; 91.7% male). Eleven (91.6%) completed all four preoperative cycles and proceeded to surgery. Mean RDI was 76.7%. Pre-emptive dose capping was the predominant dose modification strategy, with only one reactive dose reduction. Two grade 3 adverse events occurred. Major pathological response (Mandard grade 1–2) was observed in 2/12 patients (16.7%). Mean estimated LBM declined from 54.3 to 53.4 kg. Greater LBM loss appeared to coincide with poorer clinical outcomes.

Conclusions High treatment completion and progression to surgery were achieved despite reduced RDI. These findings support prospective evaluation of strategies to optimise chemotherapy delivery while maintaining tolerability in routine clinical practice.

What is already known on this topic?Perioperative FLOT is standard treatment for resectable gastric and gastro-oesophageal junction adenocarcinoma, but toxicity frequently necessitates dose modification. Real-world data on relative dose intensity and treatment completion remain limited.

What this study adds?In this single-centre cohort, 91.6% of patients completed all four planned preoperative FLOT cycles and proceeded to surgery despite a mean relative dose intensity of 76.7%. Pre-emptive dose capping was the predominant dose-modification strategy.

How this study might affect research, practice or policy?Routine monitoring of relative dose intensity alongside treatment completion may provide a useful measure of chemotherapy delivery. Larger studies should evaluate whether individualised dose optimisation can maintain treatment continuity while balancing toxicity and dose intensity.

Competing Interest Statement

The authors have declared no competing interest.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No ethics approval was required, the service evaluation was registred with York and Scarborough clinical governance team and the dataset used for fully anonymised, no patient consent was required for this. The evaluation was registered with the hospital clinical governance department (CSCS/ONC/142).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors. These will be shortly uploaded to zenodo (the data file)

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 21, 2026.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Real-world perioperative FLOT delivery in gastric and gastro-oesophageal junction adenocarcinoma: a single-centre service evaluation in a District General Hospital in the UK
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Real-world perioperative FLOT delivery in gastric and gastro-oesophageal junction adenocarcinoma: a single-centre service evaluation in a District General Hospital in the UK
Riya Sabharwal, Divyalakshmi Bhaskaran
medRxiv 2026.10.19.26365836; doi: https://doi.org/10.64898/2026.10.19.26365836
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Real-world perioperative FLOT delivery in gastric and gastro-oesophageal junction adenocarcinoma: a single-centre service evaluation in a District General Hospital in the UK
Riya Sabharwal, Divyalakshmi Bhaskaran
medRxiv 2026.10.19.26365836; doi: https://doi.org/10.64898/2026.10.19.26365836

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (638)
  • Allergy and Immunology (917)
  • Anesthesia (350)
  • Cardiovascular Medicine (5000)
  • Dentistry and Oral Medicine (495)
  • Dermatology (428)
  • Emergency Medicine (676)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1690)
  • Epidemiology (16253)
  • Forensic Medicine (36)
  • Gastroenterology (1241)
  • Genetic and Genomic Medicine (7274)
  • Geriatric Medicine (751)
  • Health Economics (1093)
  • Health Informatics (5284)
  • Health Policy (1467)
  • Health Systems and Quality Improvement (1832)
  • Hematology (599)
  • HIV/AIDS (1381)
  • Infectious Diseases (except HIV/AIDS) (16484)
  • Intensive Care and Critical Care Medicine (1203)
  • Medical Education (700)
  • Medical Ethics (156)
  • Nephrology (751)
  • Neurology (7586)
  • Nursing (377)
  • Nutrition (1129)
  • Obstetrics and Gynecology (1295)
  • Occupational and Environmental Health (1040)
  • Oncology (3742)
  • Ophthalmology (1093)
  • Orthopedics (409)
  • Otolaryngology (465)
  • Pain Medicine (501)
  • Palliative Medicine (143)
  • Pathology (721)
  • Pediatrics (1858)
  • Pharmacology and Therapeutics (755)
  • Primary Care Research (786)
  • Psychiatry and Clinical Psychology (6124)
  • Public and Global Health (9986)
  • Radiology and Imaging (2529)
  • Rehabilitation Medicine and Physical Therapy (1516)
  • Respiratory Medicine (1268)
  • Rheumatology (658)
  • Sexual and Reproductive Health (804)
  • Sports Medicine (595)
  • Surgery (803)
  • Toxicology (109)
  • Transplantation (318)
  • Urology (307)